FDA inspection
The Procter & Gamble Company: FDA inspection ending Nov 4, 2010
FDA inspection 696655 · No Action Indicated (NAI) · Cincinnati, OH
Key facts
| Inspection ID | 696655 |
|---|---|
| Firm | The Procter & Gamble Company |
| FEI number | 3003601023 |
| Address | 1 Procter And Gamble Plz |
| City | Cincinnati |
| State | OH |
| ZIP | 45202 |
| Country | United States |
| Fiscal year | 2011 |
| Inspection end date | Nov 4, 2010 |
| Classification | No Action Indicated (NAI) |
| Project area | Unapproved and Misbranded Drugs |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data